| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc Common Stock (DE) | $1.7b | $25.29 | -6.1% | 315.3K | |
| Arbutus Biopharma Corporation Common Stock | $0.9b | $4.24 | -2.5% | 1.1M | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $106.9m | $0.83 | -7.9% | 846.1K | |
| Clene Inc. Common Stock | $83.8m | $5.46 | -6.2% | 114.7K | |
| Zentek Ltd. Common Stock | $63.8m | $0.53 | 0.0% | 62.1K | |
| NanoViricides Inc. | $40.5m | $1.44 | -4.0% | 682.9K | |
| Polyrizon Ltd. Ordinary Shares | $32.1m | $13.22 | +3.3% | 48.2K | |
| Lexaria Bioscience Corp. Common Stock | $14.9m | $0.64 | +0.7% | 54.9K | |
| Aspire Biopharma Holdings, Inc. Common Stock | $7.1m | $5.62 | -7.1% | 87.2K | |
| TransCode Therapeutics, Inc. Common Stock | $4.9m | $5.68 | -2.7% | 100.0K |